Affordable Access

Access to the full text

RUNX2 interacts with BRG1 to target CD44 for promoting invasion and migration of colorectal cancer cells

Authors
  • Yan, Xiaodong1
  • Han, Dali2
  • Chen, Zhiqiang1
  • Han, Chao3
  • Dong, Wei2
  • Han, Li2
  • Zou, Lei2
  • Zhang, Jianbo4
  • Liu, Yan2
  • Chai, Jie5, 6
  • 1 Capital Medical University, Beijing, 100069, China , Beijing (China)
  • 2 Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong Province, 250117, China , Jinan (China)
  • 3 Heping Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi Province, 046000, China , Changzhi (China)
  • 4 Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong Province, 250117, China , Jinan (China)
  • 5 Shandong First Medical University and Shandong Academy of Medical Sciences, No. 440 Ji-Yan Road, Jinan, Shandong Province, 250117, China , Jinan (China)
  • 6 Tianjin Medical University, Tianjin, 300070, China , Tianjin (China)
Type
Published Article
Journal
Cancer Cell International
Publisher
Springer (Biomed Central Ltd.)
Publication Date
Oct 15, 2020
Volume
20
Issue
1
Identifiers
DOI: 10.1186/s12935-020-01544-w
Source
Springer Nature
Keywords
License
Green

Abstract

BackgroundCancer stem cells (CSCs) play an important role in tumor invasion and metastasis. CD44 is the most commonly used marker of CSCs, with the potential to act as a determinant against the invasion and migration of CSCs and as the key factor in epithelial–mesenchymal transition (EMT)-like changes that occur in colorectal cancer (CRC). Runt-related transcription factor-2 (RUNX2) is a mesenchymal stem marker for cancer that is involved in stem cell biology and tumorigenesis. However, whether RUNX2 is involved in CSC and in inducing EMT-like changes in CRC remains uncertain, warranting further investigation.MethodsWe evaluated the role of RUNX2 in the invasion and migration of CRC cells as a promoter of CD44-induced stem cell- and EMT-like modifications. For this purpose, western blotting was employed to analyze the expression of differential proteins in CRC cells. We conducted sphere formation, wound healing, and transwell assays to investigate the biological functions of RUNX2 in CRC cells. Cellular immunofluorescence and coimmunoprecipitation (co-IP) assays were performed to study the relationship between RUNX2 and BRG1. Real-time quantitative PCR (RT-qPCR) and immunohistochemistry (IHC) were performed to analyze the expressions of RUNX2, BRG1, and CD44 in the CRC tissues.ResultsWe found that RUNX2 could markedly induce the CRC cell sphere-forming ability and EMT. Interestingly, the RUNX2-mediated EMT in CRC cell may be associated with the activation of CD44. Furthermore, RUNX2 was found to interact with BRG1 to promote the recruitment of RUNX2 to the CD44 promoter.ConclusionsOur cumulative findings suggest that RUNX2 and BRG1 can form a compact complex to regulate the transcription and expression of CD44, which has possible involvement in the invasion and migration of CRC cells.

Report this publication

Statistics

Seen <100 times